Cargando…

Tris(piperazinediium) phosphatododeca­molybo(V,VI)phosphate

The title compound, (C(4)H(12)N(2))(3)[PMo(12)O(40)] or (H(2)pip)(3)[PMo(12)O(40)] (pip is piperazine), was prepared under hydro­thermal conditions. The asymmetric unit contains one-sixth of a mixed-valent Mo(V,VI) pseudo-Keggin-type [PMo(12)O(40)](6−) anion and half a piperazinediium cation, (H(2)p...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yu-kun, Xu, Ji-qing, Yu, Hai-hui
Formato: Texto
Lenguaje:English
Publicado: International Union of Crystallography 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2983689/
https://www.ncbi.nlm.nih.gov/pubmed/21580216
http://dx.doi.org/10.1107/S1600536810002473
_version_ 1782191933471326208
author Lu, Yu-kun
Xu, Ji-qing
Yu, Hai-hui
author_facet Lu, Yu-kun
Xu, Ji-qing
Yu, Hai-hui
author_sort Lu, Yu-kun
collection PubMed
description The title compound, (C(4)H(12)N(2))(3)[PMo(12)O(40)] or (H(2)pip)(3)[PMo(12)O(40)] (pip is piperazine), was prepared under hydro­thermal conditions. The asymmetric unit contains one-sixth of a mixed-valent Mo(V,VI) pseudo-Keggin-type [PMo(12)O(40)](6−) anion and half a piperazinediium cation, (H(2)pip)(2+). The discrete Keggin-type [PMo(12)O(40)](6- )anion has [Image: see text] site symmetry and the three (H(2)pip)(2+) cations each have [Image: see text] site symmetry at the centres of the mol­ecules. The central P atom is on special position [Image: see text], which is a roto-inversion position and generates the disorder of the PO(4) tetra­hedron. Furthermore, six doubly bridging oxide groups are also disordered with an occupancy factor of 0.5 for each O atom. The anions and cations are linked by an extensive network of inter­molecular N—H⋯O and C—H⋯O hydrogen bonds.
format Text
id pubmed-2983689
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-29836892010-12-30 Tris(piperazinediium) phosphatododeca­molybo(V,VI)phosphate Lu, Yu-kun Xu, Ji-qing Yu, Hai-hui Acta Crystallogr Sect E Struct Rep Online Metal-Organic Papers The title compound, (C(4)H(12)N(2))(3)[PMo(12)O(40)] or (H(2)pip)(3)[PMo(12)O(40)] (pip is piperazine), was prepared under hydro­thermal conditions. The asymmetric unit contains one-sixth of a mixed-valent Mo(V,VI) pseudo-Keggin-type [PMo(12)O(40)](6−) anion and half a piperazinediium cation, (H(2)pip)(2+). The discrete Keggin-type [PMo(12)O(40)](6- )anion has [Image: see text] site symmetry and the three (H(2)pip)(2+) cations each have [Image: see text] site symmetry at the centres of the mol­ecules. The central P atom is on special position [Image: see text], which is a roto-inversion position and generates the disorder of the PO(4) tetra­hedron. Furthermore, six doubly bridging oxide groups are also disordered with an occupancy factor of 0.5 for each O atom. The anions and cations are linked by an extensive network of inter­molecular N—H⋯O and C—H⋯O hydrogen bonds. International Union of Crystallography 2010-02-06 /pmc/articles/PMC2983689/ /pubmed/21580216 http://dx.doi.org/10.1107/S1600536810002473 Text en © Lu et al. 2010 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
spellingShingle Metal-Organic Papers
Lu, Yu-kun
Xu, Ji-qing
Yu, Hai-hui
Tris(piperazinediium) phosphatododeca­molybo(V,VI)phosphate
title Tris(piperazinediium) phosphatododeca­molybo(V,VI)phosphate
title_full Tris(piperazinediium) phosphatododeca­molybo(V,VI)phosphate
title_fullStr Tris(piperazinediium) phosphatododeca­molybo(V,VI)phosphate
title_full_unstemmed Tris(piperazinediium) phosphatododeca­molybo(V,VI)phosphate
title_short Tris(piperazinediium) phosphatododeca­molybo(V,VI)phosphate
title_sort tris(piperazinediium) phosphatododeca­molybo(v,vi)phosphate
topic Metal-Organic Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2983689/
https://www.ncbi.nlm.nih.gov/pubmed/21580216
http://dx.doi.org/10.1107/S1600536810002473
work_keys_str_mv AT luyukun trispiperazinediiumphosphatododecamolybovviphosphate
AT xujiqing trispiperazinediiumphosphatododecamolybovviphosphate
AT yuhaihui trispiperazinediiumphosphatododecamolybovviphosphate